151 related articles for article (PubMed ID: 23365707)
1. Radiation necrosis of the pons after radiotherapy for nasopharyngeal carcinoma: diagnosis and treatment.
DeSalvo MN
J Radiol Case Rep; 2012 Jul; 6(7):9-16. PubMed ID: 23365707
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab reverses cerebral radiation necrosis.
Wong ET; Huberman M; Lu XQ; Mahadevan A
J Clin Oncol; 2008 Dec; 26(34):5649-50. PubMed ID: 18981459
[No Abstract] [Full Text] [Related]
3. Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study.
Boström JP; Seifert M; Greschus S; Schäfer N; Glas M; Lammering G; Herrlinger U
Strahlenther Onkol; 2014 Apr; 190(4):416-21. PubMed ID: 24429478
[TBL] [Abstract][Full Text] [Related]
4. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
[TBL] [Abstract][Full Text] [Related]
5. Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management.
Chen J; Dassarath M; Yin Z; Liu H; Yang K; Wu G
Radiat Oncol; 2011 Sep; 6():128. PubMed ID: 21961805
[TBL] [Abstract][Full Text] [Related]
6. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
Furuse M; Kawabata S; Kuroiwa T; Miyatake S
J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
[TBL] [Abstract][Full Text] [Related]
8. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab alleviates radiation-induced brain necrosis: A report of four cases.
Xiang-Pan L; Yuxin C; Xiao-Fei W; Na L; Tang-Peng X; Xiao-Tao X; Chang-Li R; Wei-Guo H; Qi-Bin S
J Cancer Res Ther; 2015; 11(2):485-7. PubMed ID: 26148625
[TBL] [Abstract][Full Text] [Related]
10. Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis.
Benoit A; Ducray F; Cartalat-Carel S; Psimaras D; Ricard D; Honnorat J
J Neurol; 2011 Feb; 258(2):328-9. PubMed ID: 20862487
[No Abstract] [Full Text] [Related]
11. Intravitreal bevacizumab for radiation-induced cystoid macular oedema in patients with nasopharyngeal carcinoma: a clinical series.
Subrayan V; Khaw KW; Peyman M; Koay AC; Tajunisah I
Ophthalmologica; 2013; 229(4):208-11. PubMed ID: 23548379
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
Lubelski D; Abdullah KG; Weil RJ; Marko NF
J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
[TBL] [Abstract][Full Text] [Related]
13. Radiation retinopathy after external beam irradiation for nasopharyngeal carcinoma: A case report and review of the literature.
Bawankar P; Barman M; Bhattacharjee H; Soibam R; Paulbuddhe V
Pract Radiat Oncol; 2018; 8(6):366-368. PubMed ID: 29861351
[No Abstract] [Full Text] [Related]
14. Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.
Lee NY; Zhang Q; Pfister DG; Kim J; Garden AS; Mechalakos J; Hu K; Le QT; Colevas AD; Glisson BS; Chan AT; Ang KK
Lancet Oncol; 2012 Feb; 13(2):172-80. PubMed ID: 22178121
[TBL] [Abstract][Full Text] [Related]
15. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.
Torcuator R; Zuniga R; Mohan YS; Rock J; Doyle T; Anderson J; Gutierrez J; Ryu S; Jain R; Rosenblum M; Mikkelsen T
J Neurooncol; 2009 Aug; 94(1):63-8. PubMed ID: 19189055
[TBL] [Abstract][Full Text] [Related]
16. Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings.
Chong VF; Rumpel H; Fan YF; Mukherji SK
Eur Radiol; 2001; 11(2):317-24. PubMed ID: 11218034
[TBL] [Abstract][Full Text] [Related]
17. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study.
Artzi M; Bokstein F; Blumenthal DT; Aizenstein O; Liberman G; Corn BW; Ben Bashat D
Eur J Radiol; 2014 Jul; 83(7):1250-1256. PubMed ID: 24809637
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
Liu AK; Macy ME; Foreman NK
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1148-54. PubMed ID: 19857784
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
Dahl NA; Liu AK; Foreman NK; Widener M; Fenton LZ; Macy ME
Childs Nerv Syst; 2019 Nov; 35(11):2043-2046. PubMed ID: 31367784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
